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NMRWith more than half the world's population living at risk of malaria infection, there is a strong demand for the
development of an effective malaria vaccine. One promising vaccine candidate is merozoite surface protein 2
(MSP2), which is among the most abundant antigens of the blood stage of the Plasmodium falciparum para-
site. In solution, MSP2 is intrinsically unstructured, but little is known about the conformation of native
MSP2, which is GPI-anchored to the merozoite surface, or of the implications of that conformation for the im-
mune response induced by MSP2. Initial NMR studies have shown that MSP2 interacts with lipid micelles
through a highly conserved N-terminal domain. We have further developed these ﬁndings by investigating
how different lipid environments affect the protein structure. All of the tested lipid preparations perturbed
only the N-terminal part of MSP2. In DPC micelles this region adopts an α-helical structure which we have
characterized in detail. Our ﬁndings suggest a possible mechanism by which lipid interactions might modu-
late immune recognition of the conserved N-terminus of MSP2, potentially explaining the apparent immuno-
dominance of the central variable region of this important malaria antigen.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Antigens on the surface of the Plasmodium falciparummerozoite rep-
resent attractive candidates for inclusion in a malaria vaccine [1].
Merozoite surface protein 2 (MSP2) is a ~28 kDa protein anchored to
the merozoite membrane by a C-terminal glycosylphosphatidylinositol
(GPI)moiety [2] and is oneof themost abundant proteins on the surface
of themerozoite [3]. Because of its localisation at themerozoite surface,
MSP2 is directly accessible to immune recognition by plasma anti-
bodies. People naturally-exposed to malaria acquire high levels of
anti-MSP2 antibodies and these responses have been associated with
protection from symptomatic disease [4–9]. For these reasons, vaccines
incorporating MSP2 are under active development [1,10,11]. Recent
clinical trials of MSP2-based vaccines have established their safety and
partial efﬁcacy, but have highlighted the need to induce a response
that better matches the speciﬁcity of the naturally acquired response
[11,12].
MSP2 exists as one of two major allelic types, FC27 and 3D7, which
are distinguished by the sequences of a highly polymorphic central re-
gion that consists of non-repeat sequences surrounding tandem repeat
sequences [13,14]. FC27 forms of MSP2 contain 32-residue andDPC, dodecyl phosphocholine;
dilauryl phosphatidylcholine;
+61 3 9903 9582.
n).
l rights reserved.12-residue repeats, whereas 3D7 forms of the antigen contain much
shorter repeats. The diversity of the central regions is likely to have
evolved under immune pressure from the human host [14]. All MSP2 al-
leles have conserved 25-residue N-terminal and ~50-residue C-terminal
amino acid sequences that ﬂank the central variable region (Fig. 1, Sup-
plementary Figure S1). An MSP2 construct has been expressed in E. coli
where the central variable region was deleted, leaving the N- and
C-terminal domains joineddirectly. This recombinant construct is immu-
nogenic, but the antibodies raised have a different speciﬁcity from those
in naturally-infected hosts, and the protein was poorly recognised by
sera from malaria-exposed humans that are reactive against native
MSP2 [15]. These results suggest that the N- and C- terminal regions of
MSP2 are not exposed to the human immune system in the course of a
natural malaria infection. Recently, we have characterised a panel of
monoclonal antibodies raised against recombinant MSP2. Of this panel,
most of those that recognise the conserved regions of recombinant
MSP2 either fail to recognise, or react poorly with, MSP2 on the parasite
surface, whereas those that recognise the central variable region ofMSP2
react well with the parasite surface [16].
Recombinant MSP2 is intrinsically unstructured, with a high pro-
pensity for ﬁbril formation [17,18]. Like many malaria surface anti-
gens, MSP2 is GPI anchored to the merozoite surface. However, the
structural characteristics of MSP2 on the merozoite surface remain
unknown. GPI-mediated lipid interactions alter the antigenic proper-
ties of proteins of other parasitic organisms [19], but these issues
have not been addressed in the case of MSP2 or other malaria anti-
gens. Recently, we have shown that the conserved N-terminal region
of MSP2 interacts with dodecyl phosphocholine (DPC) micelles, in the
Fig. 1. Schematic of the two families of MSP2, FC27 and 3D7.
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teractions may play a role in determining the apparent immuno-
dominance of the central variable region of MSP2. Here we
undertake a detailed structural characterisation of the interaction of
MSP2 with lipid surfaces, in order to understand the implications
for the interactions of MSP2 with the host immune system and with
a view to designing more effective MSP2-based malaria vaccines.
2. Experimental procedures
2.1. Materials
All studies describedherewere carried outwith the recombinant FC27
allelic form of MSP2 expressed in E. coli. Untagged full-length FC27 MSP2
was expressed and puriﬁed using a strategy speciﬁc for recombinantly
expressed unstructured proteins, as described previously [18]. Truncated
FC27 MSP2 (MSP21-25) was either expressed and puriﬁed according to
the protocol by Low et al. [20] or purchased as a synthetic peptide from
GL Biochem (Shanghai, China). 15N-labelled full-length or truncated
MSP2was prepared by growing expression cultures inM9minimalmedi-
um, with 1 g/L 15N ammonium chloride as the sole nitrogen source.
2.2. Sample preparation
All MSP2 samples used in titration experiments were freshly pre-
pared by dissolution of freeze-dried MSP2 in the appropriate buffer
and brieﬂy heated to 95 °C to dissolve any aggregates present. Work-
ing stocks of 2H38-DPC (Cambridge Isotope Laboratories) and LPPG
(Avanti Polar Lipids) were freshly prepared in the appropriate buffer.
Lipid SUVs were prepared by suspending dry DLPC (Avanti Polar
Lipids) in buffer and subjecting the mixture to probe sonication and
vortex mixing until a stable transparent solution was achieved.
MSP21–25 samples for structure determination were prepared by dis-
solution of freeze-dried peptide directly in the buffered DPC solution
(50 mM DPC, 20 mM sodium acetate, pH 4.5).
2.3. NMR spectroscopy
Samples for NMR spectroscopy contained 5% 2H2O and 0.01% diox-
ane, the latter as an internal reference for chemical shift and diffusion
coefﬁcient measurements. NMR spectra were acquired on Bruker
Avance 500 and 600 MHz spectrometers equipped with cryoprobes,
and a Bruker DRX-600 spectrometer with a room-temperature probe.
1H chemical shifts were referenced with dioxane set as 3.751 ppm,
and 15N and 13C chemical shifts were referenced indirectly from 1H
using the ratios γN/γH=0.101329118 and γC/γH=0.251449453 [21].
Two-dimensional 1H-15N HSQC spectra were typically acquired with
2048 (1H) and 256 (15N) points and spectral widths of 9 ppm (1H)
and 24 ppm (15N). Diffusion measurements were performed using a
pulsed ﬁeld gradient longitudinal eddy-current delay pulse sequence,
as implemented by Yao et al. [22]; a series of 12 spectra was acquired
with the strength of the diffusion gradient varying from 3.44 G cm−1to 36.22 G cm−1. NMR Spectra were processed using Bruker Topspin
or NMRpipe [23], and assignment of MSP21–25 was done in SPARKY
[24].
2.4. Structure calculation
A structural ensemble of MSP21-25 was calculated based on NOE re-
straints derived from the2DNOESY spectrum. Calibration ofNOEdistance
restraints and initial structure calculations were carried out using CYANA
(version 1.0.6).φ-angles were restricted to negative values (−90°±90°)
[25], and, for residues shown by chemical shift and NOE patterns to be in
the α-helical region of MSP21–25, the φ and ψ angles were restricted fur-
ther to−64°±30 and−40°±30°, respectively. Final structure calcula-
tions were performed in NIH-XPLOR [26], with 100 conformers
calculated with high temperature simulated annealing in torsion angle
space followed by extensive Cartesian annealing and reﬁnement. The
ﬁnal ensemble of 20 structures was selected on the basis of overall
XPLOR energy, with the exclusion of structures with an NOE energy
term exceeding 10 kcal/mol; this later ﬁlter being required to exclude a
small number of low-energy structureswith anomalously highNOE ener-
gy due to an obvious distortion around residue 15 in violation of several
short-range NOEs (Table 1). The structure was validated using
PROCHECK [27], with RMSD values and angular order parameters calcu-
lated usingMOLMOL [28], and other structural analysis using PyMOL [29].
3. Results
3.1. MSP2–micelle interactions
We have previously shown that under acidic conditions, recombi-
nant MSP2 lacking the C-terminal GPI anchor, interacts with zwitter-
ionic DPC micelles, despite its marked hydrophilic character [18]. To
further characterise this interaction, we performed DPC titrations
under acidic (pH 3.5 and 4.5) and neutral (pH 7.3) conditions, using
1H\15N HSQC spectra of MSP2 to monitor the interaction. Under all
of the conditions testedwe sawno change toMSP2 spectra in the pres-
ence of DPC below its critical micelle concentration (CMC) of ~1 mM,
indicating that MSP2 does not interact with isolated molecules of
DPC (data not shown). In contrast, we observed signiﬁcant changes
at micellar concentrations as MSP2 interacted with the DPC micelle.
This interaction caused substantial line-broadening and chemical
shift perturbation involving the entire conserved N terminal region,
and a few residues at the extreme C-terminus. No changes in either
chemical shift or line-shape were observed for residues in the central
variable region, or in most of the C-terminal region, indicating that
these parts of MSP2 do not interact with the DPC micelle and are
not signiﬁcantly perturbed by the interaction of the N-terminus.
The lack of line-broadening in these regions is consistent with the
highly ﬂexible nature of MSP2 [18], and indicates that these residues
are conformationally decoupled from the DPC micelle, even when
the N-terminal part of the molecule is bound.
Table 1
Structure statistics for ﬁnal 20 structures.
No. of conformational restraints
Total no. of distance restraints 591
Intraresidue (i= j) 202
Sequential (|i–j|=1) 196
Medium-range (1b |i–j|b5) 189
Long-range (|i–j|>4) 4
No. of dihedral restraints
Energiesa
ENOE (kcal mol−1) 6.4±1.7
Edihedral (kcal mol−1) 0.20±0.16
RMS deviations from experimental data
NOEs (Å) 0.019±0.003
Dihedrals (°) 0.27±0.13
Deviations from idealb
Angles (°) 0.48±0.01
Bonds (Å) 0.003
Impropers (°) 0.35±0.02
Atomic RMS deviations (Å)c
all heavy atoms 1.3±0.5
Backbone heavy atoms, residues 7–24 0.41±0.15
Ramachandran plotd
Most favoured (%) 71.7
Allowed (%) 26.9
Additionally allowed (%) 1.0
Disallowed (%) 0.4
a The values for ENOE are calculated from a square well potential with force constants
of 30 kcal mol−1 Å−2.
b The values for the bonds, angles, and impropers show the RMS deviations from
ideal covalent geometry as deﬁned by the XPLOR forceﬁeld.
c The average RMSD to the mean as calculated in MOLMOL.
d As reported by PROCHECK-NMR for all residues.
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N-terminal region were dominated by chemical shift changes, indica-
tive of an interaction that is in fast exchange on the chemical shift
timescale. As the DPC concentration was increased, line-broadening
became more signiﬁcant, to the extent that at 50 mM DPC, where
the interaction nears saturation, approximately 50% of affected reso-
nances were broadened beyond detection (Fig. 2A). The chemical
shift perturbations due to DPC showed a uniform dependence on
DPC concentration over all perturbed resonances (Fig. 2B), and in
both 1H and 15N chemical shift, indicative of a simple two-state ex-
change between free MSP2 and a single DPC-bound state.
Near neutral pH, the DPC titration affected an identical set of
MSP2 residues at the N-terminus. In contrast to the low-pH case,
these data are characterised by very few observable chemical
shift perturbations, but rather by line-broadening throughout the
conserved N-terminal region (Figs. 2C and 3B). This line broaden-
ing may be attributed either to exchange processes occurring on
an intermediate timescale or to the intrinsic relaxation properties
of the relatively large DPC-MSP2 complex. We favour the former
explanation because, as argued above, the DPC micelle is con-
formationally decoupled from the bulk of the bound MSP2 mole-
cule. Therefore we expect the rotational diffusion, and thus the
NMR relaxation, of the DPC micelle to be largely unperturbed by
the bulk of the MSP2 molecule. Intermediate timescale exchange
at neutral pH may reﬂect a slightly higher afﬁnity of MSP2 for the
micelle under these conditions.
3.2. Lipid induced MSP2 oligomer-formation
For all of the conditionswe considered, line-broadening impeded our
ability to characterise structural details of the interaction of full-length
MSP2 with DPC micelles. For this reason, we chose to investigate the
interaction of MSP2 with the acidic lysopalmitoylphosphatidyl glycerol
(LPPG), which has yielded high-quality NMR spectra for other challeng-
ing protein-lipid complexes [30,31].
Despite the markedly different head-group chemistry, the
N-terminal region of MSP2 interacts with LPPG micelles at neutral
pH in a manner similar in many respects to its interactions with
DPC. Speciﬁcally, we observe marked line-broadening of most reso-
nances in the N-terminal region of MSP2, with only a few small chem-
ical shift perturbations (Fig. 3). Strikingly, and in contrast to the case
with DPC, the LPPG-induced changes to the MSP2 spectra were ob-
served at low protein:LPPG ratios. Widespread line-broadening was
observed for the MSP2 N-terminus even at sub-stoichiometric con-
centrations of LPPG, and all spectral changes were observed to satu-
rate at MSP2:LPPG ratios around 1:5 (data not shown). The CMC of
LPPG is approximately 50 μM, 3–5 fold lower than the MSP2 concen-
trations used in these studies, and the LPPG micelle comprises ~125
molecules [32]. Thus a micellar complex under these conditions
would contain ~25 MSP2 molecules. A more plausible interpretation
of these results is that MSP2 disrupts LPPG micelles and interacts
with sub-micellar lipid complexes. Similar behaviour was observed
for the MSP2-LPPG interaction at pH 4.5 (data not shown).
In an attempt to further characterise these complexes, we mea-
sured diffusion coefﬁcients for MSP2 in the presence of increasing
LPPG concentrations. The translational diffusion coefﬁcient for
MSP2 alone under these conditions was 3.2×10−11 cm2/s, and ad-
dition of LPPG in 2.5-fold molecular excess reduced the diffusion
coefﬁcient to 2.4×10−11 cm2/s, while further addition of LPPG
caused only a small further reduction, to 2.3×10−11 cm2/s. Thus
the addition of LPPG caused an approximately 40% increase in the
effective hydrodynamic radius of MSP2. In contrast, binding to
DPC micelles caused a less than 20% increase [18]. These results
imply that MSP2 forms oligomeric complexes stabilised by
non-micellar LPPG. Such an interaction is in some respects similar
to the complexes formed by α-synuclein in the presence of lowlipid concentrations [33]. Attempts to measure the diffusion of
LPPG in these complexes were unsuccessful, due to relaxation
losses during the diffusion encoding delay. This is not the case for
LPPG micelles in the absence of MSP2, which under the same con-
ditions (1 mM in LPPG monomers) showed a signiﬁcantly higher
diffusion coefﬁcient of 4.3×10−11 cm2/s, further emphasising
that the properties of the LPPG-MSP2 complex are markedly dis-
tinct from those of LPPG micelles.3.3. MSP2–lipid bilayer interactions
To address the implications of lipid interactions for MSP2 on the
merozoite surface, we probed the interaction of MSP2 with lipid bila-
yers in the form of DLPC SUVs. Given the large size of these vesicles,
we expected resonances corresponding to lipid-bound MSP2 to be
undetectable, while those regions of MSP2 not involved in the inter-
action were expected to retain their ﬂexibility, and thus to retain
the chemical shift and relaxation properties of free MSP2 [33]. Consis-
tent with these expectations, we saw no changes in chemical shift
upon addition of lipid SUVs to MSP2 but a reduction of peak intensity
for resonances corresponding to the conserved N-terminal region
(Supplementary Figure S2). In the presence of 7.5 mM DLPC as SUVs
(protein:lipid molar ratio of 1:60), a uniform reduction in peak inten-
sities of ~20% was observed for residues of the conserved N-terminal
region. In the limit of slow exchange, the fractional change in peak in-
tensity reﬂects the proportion of MSP2 that is bound to the lipid
membrane. In this case, however, we cannot rule out a contribution
of relaxation due to intermediate exchange to the observed signal at-
tenuation. Nonetheless, it is apparent that under accessible lipid con-
centrations, the fraction of MSP2 that is lipid bound is relatively low,
suggesting that the N-terminus of MSP2 interacts only weakly with
this bilayer system. It must be stressed, however, that these observa-
tions were made in the absence of the GPI anchor which tethers
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presence of the GPI anchor would be expected to substantially en-
hance the effect of these weak lipid interactions.
3.4. Structure of DPC-bound MSP2 N-terminus
To obtain more information on the structural changes in the
N-terminus, we titrated DPC into a solution of a recombinant peptide
containing only residues 1–25 of full-length MSP2. As described previ-
ously by Low et al. [20], this peptide is conformationally very similar
to the corresponding region of full-length recombinant MSP2, as dem-
onstrated, for example, by very similar chemical shifts. On addition of
DPC, the backbone amide resonances of MSP21-25 underwent similar
chemical shift changes to those seen for the full-length protein
(Fig. 4), even though the titration with full-length MSP2 could not beFig. 2. Backbone amide chemical shift changes (Δδ=[(ΔδN/5)2+(ΔδHN)2]1/2) for MSP2
on titration with DPC. A: Chemical shift changes in the presence of 50 mM DPC in
10 mM sodium acetate, pH 4.5. for each assigned backbone amide resonance are plotted
as black bars. Grey bars denote resonances that are broadened beyond detection under
these conditions. B: DPC concentration dependence of chemical shift changes for residues
7 (●), 14(■) and 21 (♦) in 10 mM sodium acetate, pH 4.5. C: Chemical shift changes for
MSP2 in the presence of 20 mM DPC in 10 mM sodium phosphate, pH 7.3. Chemical
shift changes for each assigned backbone amide resonance are plotted as black bars.
Grey bars denote resonances that are broadened beyonddetection under these conditions.followed to completion because of excessive line broadening at the
higher DPC concentrations. Thus, we conclude that the N-terminus of
full-length MSP2 undergoes a conformational transition corresponding
to that observed for MSP21-25, and the shorter construct therefore rep-
resents an excellentmodel of this transition and the underlying lipid in-
teractions. Importantly, the degree of line broadening observed for
MSP21-25 on addition of DPC is signiﬁcantly less than that observed for
full-length MSP2 (Fig. 4 and Supplementary Figure S3), permitting a
more detailed structural investigation using this construct. The ob-
served differences in line broadening are consistent with a slower
on-rate for full-length MSP2 owing to its slower translational diffusion.
The structure of MSP21-25 has been solved using solution NMR
methods. The resonance assignmentswere based onpreviously published
data [20], supported by 3D HNCA/HNCO spectra of a 13C/15N-labelled
MSP21-25 sample. Chemical shift assignments are documented in
Supplementary Table I. All NOE-based structural restraints were
generated from high-resolution 2D NOESY data. We used a number
of different samples to collect information on the system, including
unlabelled synthetic material as well as labelled recombinant MSP2.
Only very limited changes were observed between the different
samples and all NOE restraints were based on one sample only.
Throughout the peptide, 1Hα and 13Cα chemical shifts show char-
acteristic deviations from random-coil values, indicative of α-helical
structure (Fig. 5A and Supplementary Figure S4). These deviations
are particularly pronounced for residues 10–22, and are supported
by i to i+3 NOE connectivities in this region (Fig. 5). Backbone tor-
sion angle restraints were therefore used to maintain helical confor-
mation in this region. The ﬁnal structural ensemble was calculated
using 591 NOE restraints, and 37 torsion angle restraints. As seen in
Fig. 7, the peptide adopts an α-helical structure along essentially its
full length, though the helical structure is rather poorly deﬁned in
the N-terminal 7 residues (Supplementary Figure S5). The few
long-range NOEs observed were between the side chains of residues
12 and 17, consistent with the extended helical structure. We haveFig. 3. A. 1H–15N HSQC of 0.2 mM FC27 MSP2 in 10 mM sodium phosphate, pH 7.3, in
the presence (red) and absence (blue) of 2.4 mM LPPG. B. Peak intensities for
well-resolved backbone amide resonances in the presence of 2.4 mM LPPG (black),
and in the presence of 20 mM DPC (blue) in 10 mM sodium phosphate, pH 7.3,
normalised relative to lipid-free peak intensities.
Fig. 4. 1H–15N HSQC titration of full-length FC27 MSP2 (left panel) and MSP21-25 (right panel) with DPC. Spectra were acquired at 25 °C in 20 mM sodium acetate, pH 4.5, with
0 mM (blue), 5 mM (teal), 8 mM (green), 12 mM (orange), 25 mM (pink) and 50 mM (red) DPC.
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(TFE) on the aggregation properties of MSP2 [34]. TFE induces helical
structure in the N-terminus of MSP2, and the structure of MSP21-25 in
50% TFE is similar in many respects to that described here, with a
well-deﬁned helical conformation observed in the C-terminal
two-thirds of the peptide. As noted in the context of the TFE structure,
this helix is imperfectly amphipathic; in the current structure two
distinct hydrophobic faces can be detected on the helix, differing in
their orientation by ~90° (Fig. 6B).Fig. 5. Secondary Cα chemical shifts (A) and summary of sequential and medium range
NOEs (B) measured for recombinant MSP21-25 in the presence of 50 mM DPC, pH 4.5 at
25 °C. Residue numbering is as for full-length MSP2, with the vector-derived N-terminal
residues GSM numbered -2, -1 and 0.4. Discussion
Despite its status as an important candidate for inclusion in a ma-
laria vaccine, little is known of the structural properties of MSP2 on
the merozoite surface, or of the implications of these properties for
the development of a protective immune response [1]. In particular,
it is unclear how MSP2 interacts with the merozoite plasma mem-
brane to which it is GPI anchored. GPI-mediated lipid interactions
alter the antigenic properties of proteins of other parasitic organisms
[19], but this has not been studied in the case of MSP2 or other malar-
ia antigens. To begin to address these issues, we have probed the in-
teractions of recombinant MSP2 with lipid-mimetic micelles and
lipid bilayers using NMR spectroscopy. We observe a consistent inter-
action of the conserved N-terminal region of MSP2 to these lipids
over a range of pH values and diverse lipid head-groups. Although
line broadening, most likely the result of intermediate time-scale ex-
change between free and boundMSP2, has limited our ability to char-
acterise in detail the structure of full-length MSP2-lipid complexes,
we have established that an N-terminal fragment of MSP2 serves as
an excellent model of these complexes.
Although the interactions we characterise here are of relatively low
apparent afﬁnity, the fact that MSP2 is covalently attached to themero-
zoite membrane by its C-terminal GPI anchor strongly enhances the
likelihood that such interactions might modulate the conformational
and immunogenic properties ofMSP2 on themerozoite surface. Assum-
ing that the ~200 residues of MSP2 between the N-terminal region and
the GPI anchor resemble a random coil, as they do for the recombinant
protein in vitro [18], the MSP2 N-terminus is free to sample a hemi-
spherical region near the site of the C-terminal anchor of RMS radius
~12 nm [35], giving an effective concentration of the N-terminus at
the membrane of the order of 1 mM. Under these conditions even
weak lipid-MSP2 interactions will be signiﬁcantly populated. A possible
model of MSP2 on the merozoite surface that is consistent with our ob-
servations is shown in Fig. 7, althoughwe note that MSP2may populate
other states, including self-associated species [17].
Several lines of evidence suggest that the central variable region
dominates the immune response to MSP2 in natural protective immu-
nity against malaria [15], and in those vaccinated with MSP2 [12]. The
mechanism by which the conserved N- and C-terminal regions of
MSP2 are apparently protected from immune recognition remains ob-
scure. The results presented here allow us to suggest that interactions
with the merozoite surface membrane may have a role in mediating
Fig. 6. NMR structure of MSP21–25 in DPC micelles. A. Cα trace of the ensemble of 20 cal-
culated structures, superimposed over residues 7–24. B. Space ﬁlling model of the clos-
est to average structure in the same orientation as A (top) and rotated by 90° about the
helical axis (bottom). Hydrophobic residues are grey, neutral hydrophilic residues gold,
acidic residues red and basic residues blue. Residues comprising the two hydrophobic
faces are labelled.
Fig. 7. A possible model of MSP2 on the merozoite surface. The conserved N-terminal
region (red) is stabilized as a helix by lipid interactions, and the C-terminal region
(green) is proximal to the membrane due to the GPI anchor. The central variable region
is exposed to the host immune system.
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may be mediated by the conformational transition that accompanies
lipid binding, as the N-terminal region of lipid-free MSP2 populates
the helical state only very weakly. Alternatively, lipid interactions may
offer protection from immune surveillance by way of simple occlusion
of antibodies from the juxtamembrane region by the dense proteina-
ceous coat that surrounds the merozoite [36]. This later possibility
seems less likely given that antibodies to juxtamembrane domains of
othermerozoite antigens includingMSP1 andAMA1 recognise themer-
ozoite surface and inhibit parasite growth [37,38]. It will be of interest,
therefore, to explore the role of lipid interactions and the GPI anchor in
modulating the immune response to MSP2, with a view to developing
MSP2-based antigens better able to mimic the natural immune re-
sponse and leading to a more effective malaria vaccine.
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